Search results - 17 results
Might Oral Human Papillomavirus (HPV) Infection in Healthy Individuals Explain Differences in HPV-Attributable Fractions in Oropharyngeal Cancer? A Systematic Review and Meta-analysis.
review was performed to identify studies in which at least 50 healthy individuals were tested for oral HPV infection. Information on sex, age, tobacco/alcohol consumption, sex practices, specimen ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
can be triaged accurately with a high-risk human papillomavirus (hrHPV) test to identify those who need a referral. However, the triage of low-grade squamous intraepithelial lesion (LSIL) with hrHPV ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 2 on Triage, Treatment and Follow-up.
repeat invitation letters or an HPV self-collection kit. Colposcopy should be carried out for further investigation if cytology findings are Pap II-p and HPV test results are positive or if the results of ...
Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017)- Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
HPV-based screening. Co-testing can also be carried out. Women between the ages of 20 and 35 should have cytological screening every 2 years. Health Topics: Quality of healthcare Cancer Qualité des soins de ...
Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
led to the use of sensitive HPV molecular tests for screening. This study examined the impact of the baseline HPV status on the future risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2 ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
Publication Type: Peer reviewed scientific article Authors: M. Arbyn; Smith, Sara B; Temin, Sarah; Sultana, Farhana; Castle, Philip; Collaboration on Self-Sampling and HPV Testing Source: BMJ, ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
HPV assays with genotyping capability. In VALGENT-3, the clinical and analytical performance of Anyplex II HPV HR detection (Anyplex) was compared to that of the Hybrid Capture 2 HPV DNA test (hc2) and ...
Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Keywords: Confidence Intervals DNA, Viral Early Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening Papillomaviridae Papillomavirus Infections Practice ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
C Cocuzza; F H Zhao; S Van Keer; A Vorsters Source: J Clin Virol, Volume 107 (2018) Keywords: cervical cancer diagnostic test accuracy SCREENING self-sampling Test validation Urine collection VALHUDES ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
Alphapapillomavirus Cervical Intraepithelial Neoplasia Cervix Uteri Diagnostic Tests, Routine DNA, Viral Early Detection of Cancer Female Genotyping Techniques Humans Papillomavirus Infections Uterine Cervical ...